INCPF
Price:
$2.13
Market Cap:
$19.47B
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. The company is also developing ICP-192, a pan-FGFR inhibitor that is in a Phase I/...[Read more]
Industry
Biotechnology
IPO Date
2021-07-09
Stock Exchange
OTC
Ticker
INCPF
According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is -106.50. This represents a change of 383.33% compared to the average of -22.03 of the last 4 quarters.
The mean historical PE Ratio of InnoCare Pharma Limited over the last ten years is -50.72. The current -106.50 PE Ratio has changed 20.90% with respect to the historical average. Over the past ten years (40 quarters), INCPF's PE Ratio was at its highest in in the March 2025 quarter at 213.03. The PE Ratio was at its lowest in in the September 2024 quarter at -211.89.
Average
-50.72
Median
-21.08
Minimum
-263.75
Maximum
-5.13
Discovering the peaks and valleys of InnoCare Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 829.75%
Maximum Annual PE Ratio = -5.13
Minimum Annual Increase = -92.38%
Minimum Annual PE Ratio = -263.75
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -22.06 | 30.72% |
| 2023 | -16.87 | -16.05% |
| 2022 | -20.10 | -92.38% |
| 2021 | -263.75 | 829.75% |
| 2020 | -28.37 | 453.12% |
| 2019 | -5.13 | -73.82% |
| 2018 | -19.59 | -34.48% |
The current PE Ratio of InnoCare Pharma Limited (INCPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-19.68
5-year avg
-70.23
10-year avg
-50.72
InnoCare Pharma Limited’s PE Ratio is less than Shanghai Junshi Biosciences Co., Ltd. (-38.88), less than Genscript Biotech Corporation (0.73), less than ALK-Abelló A/S (49.98), less than Laboratorios Farmaceuticos Rovi, S.A. (23.16), less than Zealand Pharma A/S (5.38), less than Camurus AB (publ) (46.07), less than COSMOS Pharmaceutical Corporation (18.97), less than Fielmann AG (21.14), less than Clicks Group Limited (27.28), less than Gedeon Richter PLC (7.97),
| Company | PE Ratio | Market cap |
|---|---|---|
| -38.88 | $5.81B | |
| 0.73 | $4.62B | |
| 49.98 | $7.26B | |
| 23.16 | $4.63B | |
| 5.38 | $5.62B | |
| 46.07 | $3.83B | |
| 18.97 | $3.83B | |
| 21.14 | $4.93B | |
| 27.28 | $4.90B | |
| 7.97 | $4.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is InnoCare Pharma Limited's PE Ratio?
How is the PE Ratio calculated for InnoCare Pharma Limited (INCPF)?
What is the highest PE Ratio for InnoCare Pharma Limited (INCPF)?
What is the 3-year average PE Ratio for InnoCare Pharma Limited (INCPF)?
What is the 5-year average PE Ratio for InnoCare Pharma Limited (INCPF)?
How does the current PE Ratio for InnoCare Pharma Limited (INCPF) compare to its historical average?